Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.

Momtaz, Parisa; Harding, James J; Ariyan, Charlotte; Coit, Daniel G; Merghoub, Taha; Gasmi, Billel; You, Daoqi; Viale, Agnes; Panageas, Katherine S; Samoila, Aliaksandra; Postow, Michael A; Wolchok, Jedd D; Chapman, Paul B

Momtaz, Parisa; Harding, James J; Ariyan, Charlotte; Coit, Daniel G; Merghoub, Taha; Gasmi, Billel; You, Daoqi; Viale, Agnes; Panageas, Katherine S; Samoila, Aliaksandra; Postow, Michael A; Wolchok, Jedd D; Chapman, Paul B.

Afiliação

Momtaz P; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Harding JJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ariyan C; Weill Cornell Medical College, New York, New York, USA.
Coit DG; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Merghoub T; Weill Cornell Medical College, New York, New York, USA.
Gasmi B; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
You D; Weill Cornell Medical College, New York, New York, USA.
Viale A; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Panageas KS; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Samoila A; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Postow MA; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wolchok JD; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Chapman PB; Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Oncotarget ; 8(62): 105000-105010, 2017 Dec 01.

Article em En | MEDLINE | ID: mdl-29285228

Palavras-chave

cfDNA; digital PCR; drug cost; relapse-free survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google